Filters: keyword is Membrane Proteins [Clear All Filters]
- 2005
Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors,
Rheumatology (Oxford), vol. 44, no. 7, pp. 846-59.
- 1999
A combined specific target site binding and pharmacokinetic model to explore the non-linear disposition of draflazine,
J Pharmacokinet Biopharm, vol. 27, no. 3, pp. 257-81.
Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(4, 4-di-(3-methylthien-2-yl)but-3-enyl) nipecotic acid in the rat,
Br J Pharmacol, vol. 128, no. 8, pp. 1651-8.
- 1998
Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazine,
J Pharmacol Exp Ther, vol. 286, no. 1, pp. 142-9.
- 1997
Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations,
Eur J Clin Pharmacol, vol. 53, no. 1, pp. 57-63.
- 1996
The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine,
Br J Clin Pharmacol, vol. 42, no. 5, pp. 605-13.
